Skip to content

LivaNova LIVN Increase in accrued expenses and other liabilities

Increase in accrued expenses and other liabilities at other companies

Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's increase in accrued expenses and other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's increase in accrued expenses and other liabilities?
LivaNova (LIVN) reported increase in accrued expenses and other liabilities of -$38.77M in Q1 2026.
How has LivaNova's increase in accrued expenses and other liabilities changed year-over-year?
LivaNova's increase in accrued expenses and other liabilities decreased by 27.1% year-over-year, from -$30.52M to -$38.77M.
What does increase in accrued expenses and other liabilities mean?
Measures the net change in short-term obligations, such as accrued compensation, legal reserves, or other operational expenses not yet paid. An increase in these liabilities acts as a source of operating cash flow, effectively representing short-term financing from vendors or employees. It is a key indicator of the company's short-term liquidity management.